Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
Q4 2021 vs. Q3 2021
How the institutions holding Evotec SE changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 20 | +20 |
| Shares | 0 | 6.62M | +6.62M |
| Value | $0 | $157.3M | +$157.3M |
New holders (20)
Institutions that held Evotec SE at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Artisan Partners Limited Partnership | 2,234,623 | $53.1M | 0.06% |
| Franklin Resources Inc | 1,501,879 | $35.7M | 0.01% |
| Artal Group S.A. | 1,149,425 | $27.3M | 0.80% |
| Federated Hermes, Inc. | 689,655 | $16.4M | 0.03% |
| Millennium Management LLC | 451,466 | $10.7M | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 300,288 | $7.13M | 0.03% |
| Caas Capital Management LP | 127,903 | $3.04M | 0.28% |
| Jane Street Group, LLC | 56,682 | $1.37M | 0.00% |
| Morgan Stanley | 34,388 | $816.0K | 0.00% |
| Price T Rowe Associates Inc | 22,188 | $527.0K | 0.00% |
| Marshall Wace, LLP | 16,272 | $387.0K | 0.00% |
| Point72 Hong Kong Ltd | 13,843 | $329.0K | 0.03% |
| Geode Capital Management, LLC | 12,785 | $303.0K | 0.00% |
| Bank of America Corp | 6,634 | $158.0K | 0.00% |
| UBS Group AG | 1,991 | $47.0K | 0.00% |
| Wells Fargo & Company | 1,002 | $24.0K | 0.00% |
| Reilly Financial Advisors, LLC | 420 | $10.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 130 | $3.00K | 0.00% |
| Cubist Systematic Strategies, LLC | 62 | $1.00K | 0.00% |
| Bell Investment Advisors, Inc | 22 | $1.00K | 0.00% |
Sold out (0)
Institutions that held Evotec SE at the end of Q3 2021 and filed for Q4 2021 without it.
None.